Terms: = Uterine cancer AND DDR2, NTRKR3, 4921, ENSG00000162733, Q16832, MIG20a, TYRO10
4 results:
1. Molecular Evaluation of Low-grade Low-stage Endometrial cancer With and Without Recurrence.
Matrai CE; Ohara K; Eng KW; Glynn SM; Chandra P; Chatterjee-Paer S; Motanagh S; Mirabelli S; Kurtis B; He B; Sigaras A; Gupta D; Chapman-Davis E; Holcomb K; Sboner A; Elemento O; Ellenson LH; Mosquera JM
Int J Gynecol Pathol; 2022 May; 41(3):207-219. PubMed ID: 34483300
[TBL] [Abstract] [Full Text] [Related]
2. Molecular Profiles of Mixed Endometrial Carcinoma.
Matrai C; Motanagh S; Mirabelli S; Ma L; He B; Chapman-Davis E; Kurtis B; Elemento O; Mosquera JM; Ellenson LH
Am J Surg Pathol; 2020 Aug; 44(8):1104-1111. PubMed ID: 32604171
[TBL] [Abstract] [Full Text] [Related]
3. Identification of NDRG1-regulated genes associated with invasive potential in cervical and ovarian cancer cells.
Zhao G; Chen J; Deng Y; Gao F; Zhu J; Feng Z; Lv X; Zhao Z
Biochem Biophys Res Commun; 2011 Apr; 408(1):154-9. PubMed ID: 21463610
[TBL] [Abstract] [Full Text] [Related]
4. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix.
Green J; Kirwan J; Tierney J; Vale C; Symonds P; Fresco L; Williams C; Collingwood M
Cochrane Database Syst Rev; 2005 Jul; 2005(3):CD002225. PubMed ID: 16034873
[TBL] [Abstract] [Full Text] [Related]
